Companies: 10,795·Total market cap: $144.5T
AlloVir, Inc.

AlloVir, Inc.

ALVRNASDAQHealthcare
$9.81
+$0.39(+4.14%)
Market Cap$49475362
P/E Ratio
52W High$24.15
52W Low$7.96
Overview

AlloVir, Inc. (ALVR) · Cash Flow

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · ALVR · as of 2026-06-10

Financial statements

Operating CF · CapEx · Free Cash Flow
Breakdown2025-122024-122023-122022-122021-12
Operating Activities
Net Income($0.04B)($0.06B)($0.19B)($0.17B)($0.17B)
Depreciation & Amort.($0.00B)$0.00B$0.00B$0.00B$0.00B
Stock-Based Comp.$0.00B$0.03B$0.04B$0.04B$0.04B
Change in Working Capital$0.00B($0.03B)$0.00B($0.02B)$0.02B
Net Cash from Operations($0.04B)($0.07B)($0.12B)($0.14B)($0.11B)
Investing Activities
Capital Expenditure($0.00B)$0.00B$0.00B$0.00B($0.00B)
Purchases of Investments($0.03B)$0.00B($0.13B)($0.23B)($0.08B)
Sales of Investments$0.01B$0.10B$0.16B$0.15B$0.26B
Net Cash from Investing($0.02B)$0.10B$0.04B($0.08B)$0.19B
Financing Activities
Common Stock Repurchased$0.00B$0.00B$0.00B$0.00B$0.00B
Dividends Paid$0.00B$0.00B$0.00B$0.00B$0.00B
Debt Issued / Repaid$0.00B$0.00B$0.00B$0.00B$0.00B
Net Cash from Financing$0.16B$0.00B$0.07B$0.13B$0.00B
Free Cash Flow
Free Cash Flow($0.04B)($0.07B)($0.12B)($0.14B)($0.11B)
FCF Margin %(computed)

Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B

Explore more AlloVir, Inc. data

About AlloVir, Inc. (ALVR) Cash Flow Statement

AlloVir, Inc. generated operating cash flow of ($0.04B) and free cash flow of ($0.04B) for 2025 — a FCF margin of —. Capital expenditure was ($0.00B).

Frequently asked questions

ALVR · 4 questions

AlloVir, Inc. generated free cash flow of ($0.04B) for 2025, up 43.0% year-over-year.

ALVR free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10